<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154636">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01810991</url>
  </required_header>
  <id_info>
    <org_study_id>CYN12-1440-BK-HID1</org_study_id>
    <nct_id>NCT01810991</nct_id>
  </id_info>
  <brief_title>Investigation of Hyperhidrosis Treatment Using the Nd: YAG 1440nm Wavelength Laser</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cynosure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cynosure, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of the Nd:YAG 1440 nm
      wavelength laser for the treatment of primary hyperhidrosis of the axilla.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Photographic evaluation as a measure of improvement</measure>
    <time_frame>up to 6 months post treatment</time_frame>
    <safety_issue>No</safety_issue>
    <description>2D photography to be taken at various time points.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject biopsy sampling</measure>
    <time_frame>up to 3 months post last treatment</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Histological examination of tissue samples pre-treatment and post-treatment as a measure of safety and tolerability</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>HYPERHIDROSIS</condition>
  <arm_group>
    <arm_group_label>Nd:YAG Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nd:YAG 1440nm Laser</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nd:YAG Laser</intervention_name>
    <description>Nd:YAG 1440nm Laser</description>
    <arm_group_label>Nd:YAG Laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A healthy non-smoking male or female between 18-56 years of age

          -  Understand/accept obligation not to receive any other procedures in anatomical areas
             exhibiting axillary hyperhidrosis through 3 months prior to treatment

          -  Understand and accept the obligation and is logistically able to present for all
             scheduled follow-up visits

          -  Clinically diagnosed for primary hyperhidrosis of the axilla.

          -  A self assessed HDSS score of three (3) or four (4)

        Exclusion Criteria:

          -  Clinical diagnosis of secondary hyperhidrosis

          -  Uncontrolled systemic disease

          -  Concurrent use of any hyperhidrosis treatments other than OTC antiperspirants or
             deodorants

          -  Receipt of Botox or Dysport within the past six months

          -  Patients who refuse to stop using OTC antiperspirants 24 hours prior to the day of
             surgery and each of the follow-up visits at 3 months and 6 months that Minors starch
             iodine tests may be performed.

          -  Patients using or having used within 7 days of baseline visit: cholinomimetic agents,
             anticholinergic agents, prescription antiperspirants, any herbal medicine treatments
             or any other treatments for hyperhidrosis except OTC antiperspirant or planning to
             use such agents during the course of the study.

          -  Any previous liposuction/liposculpture or any type of surgery for hyperhidrosis; OR
             any other types of treatments for hyperhidrosis in the area to be treated in the past
             6 months or planning to have any treatments for hyperhidrosis or surgery within the
             treatment area during the course of the study.

          -  Allergies to medication or local anesthesia required for the procedure

          -  A history of thrombophlebitis

          -  A history of acute infections

          -  A history of heart failure

          -  Received or is anticipated to receive antiplatelets, anticoagulants, thrombolytics,
             vitamin E or anti inflammatories within 2 weeks pre treatment

          -  An intolerance to anesthesia

          -  Any medical condition, that, in the investigator's opinion would interfere with the
             patient's participation in the study

          -  Taking medications that are photosensitive

          -  A history of keloid formation

          -  Is pregnant or has been pregnant in the last 3 months, currently breast feeding or
             planning a pregnancy during the course of the study

          -  Study subjects that can not maintain their pre-study exercise and diet routine over
             the course  of the study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Krantz</last_name>
    <role>Study Director</role>
    <affiliation>Cynosure, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Juva Skin and Laser Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 14, 2014</lastchanged_date>
  <firstreceived_date>December 6, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hyperhidrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
